Accendra Health Names Kenneth Gardner-Smith as CEO with $9.65M Compensation Package
ACH is trading near its 52-week low of $0.934 (14% above the low).
Summary
Accendra Health named Kenneth Gardner-Smith as its next CEO with a target compensation package of approximately $9.65 million, and created a new Chief Commercial Officer role filled by Scott Lloyd. The transition follows the previously announced retirement of Ed Pesicka.
Key Events · Executive and Board Changes · ACH
-
New CEO Named
Kenneth Gardner-Smith, a board member since March 2022, will become President and CEO starting October 1, 2026, succeeding Ed Pesicka who announced retirement in August.
-
CEO Compensation Package
Gardner-Smith's target annual compensation totals approximately $9.65 million: $1M base salary, $1.3M target bonus (130% of base), $6M target LTI, $650K sign-on bonus, and $2M inducement grant of cash-settled SARs.
-
New Chief Commercial Officer
Scott Lloyd, formerly Chief Development and Strategy Officer at Evergreen Nephrology, will join as Chief Commercial Officer effective October 5, 2026, in a newly created role.
-
Leadership Transition Context
The transition follows a Q2 loss of $1.16 per share, cash reserves of only $7.7 million, and a major debt restructuring completed in June 2026.
Analysis · ACH · Trade & Services
Accendra Health has named Kenneth Gardner-Smith as its next President and CEO, succeeding Ed Pesicka who announced retirement in August. Gardner-Smith, a board member since 2022, brings operating experience from DaVita and Veritas Veterinary Partners. His compensation package totals approximately $9.65 million in target annual value: $1 million base salary, $1.3 million target bonus, $6 million target long-term incentive, a $650,000 sign-on bonus, and a $2 million inducement grant of cash-settled stock appreciation rights. The company also created a new Chief Commercial Officer role, filled by Scott Lloyd effective October 5, 2026. This leadership transition is critical for a company that recently reported a $1.16 per-share quarterly loss, has only $7.7 million in cash, and is navigating a major debt restructuring. The new CEO's mandate is to drive growth in higher-margin categories and improve operating efficiency, but the substantial equity-based compensation package also signals the board's commitment to retaining top talent during a turnaround.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.5% of the 1626 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACH was trading at $1.06 on NYSE in the Trade & Services sector, with a market capitalization of approximately $82.3M. The 52-week trading range was $0.93 to $5.69. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.